Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients

Por Fülöp, Péter, Seres, Ildikó, Lőrincz, Hajnalka, Harangi, Mariann, Somodi, Sándor, Paragh, György
Publicado em 2014

The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters

Por Mirdamadi, Hossein Z, Sztanek, Ferenc, Derdak, Zoltan, Seres, Ildiko, Harangi, Mariann, Paragh, György
Publicado em 2008

High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus

Por Gaál, Krisztina, Tarr, Tünde, Lőrincz, Hajnalka, Borbás, Viktor, Seres, Ildikó, Harangi, Mariann, Fülöp, Péter, Paragh, György
Publicado no Lipids Health Dis (2016)

Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia

Por Varga, Viktória E., Lőrincz, Hajnalka, Zsíros, Noémi, Fülöp, Péter, Seres, Ildikó, Paragh, György, Balla, József, Harangi, Mariann
Publicado no Lipids Health Dis (2016)

Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome

Por Paragh, György, Seres, Ildikó, Harangi, Mariann, Erdei, Annamária, Audikovszky, Mária, Debreczeni, Lóránd, Kovácsay, Anna, Illyés, László, Pados, Gyula
Publicado em 2006

Serum Cystatin C Is a Determinant of Paraoxonase Activity in Hemodialyzed and Renal Transplanted Patients

Por Varga, Éva, Seres, Ildikó, Harangi, Mariann, Sztanek, Ferenc, Asztalos, László, Lõcsey, Lajos, Borbás, Béla, Szegedi, János, Kárpáti, István, Paragh, Gyórgy
Publicado em 2009